Company Filing History:
Years Active: 2022
Title: Patrick Reeves: Innovator in Cancer Treatment
Introduction
Patrick Reeves is a notable inventor based in Cambridge, MA (US), recognized for his contributions to cancer treatment through innovative therapies. He holds 2 patents that focus on enhancing the efficacy of natural killer (NK) cells in combating various forms of cancer, including inflammatory breast cancer.
Latest Patents
One of his latest patents involves the modification of natural killer cells for the treatment of cancer. This invention is directed towards treating cancers, such as inflammatory breast cancer, by enhancing the ability of NK cells to overcome the chemorepellant effects of tumors. The cells can be genetically modified ex vivo or treated with anti-chemorepellant agents to improve their effectiveness. Additionally, this invention provides ex vivo modified NK cells that express little to no CXCR4 on their surface, or express CXCR7, or a chimeric antigen receptor, among other combinations. The methods outlined in this patent also include administering these modified NK cells to patients, potentially in conjunction with conventional anticancer treatments like chemotherapy and radiotherapy.
Another significant patent by Reeves relates to anti-fugetactic agent and anti-cancer agent combination therapy. This invention describes methods and compositions for treating cancer by administering an effective amount of both an anti-fugetactic agent and an additional anti-cancer agent to patients or tumor cells.
Career Highlights
Patrick Reeves is affiliated with The General Hospital Corporation, where he continues to work on groundbreaking research in cancer therapies. His innovative approaches aim to improve patient outcomes and provide new avenues for treatment.
Collaborations
Reeves collaborates with Mark C Poznansky, contributing to the advancement of cancer treatment methodologies.
Conclusion
Patrick Reeves stands out as an influential inventor in the field of cancer treatment, with his patents reflecting a commitment to improving therapeutic strategies. His work has the potential to significantly impact the lives of patients battling cancer.